GSTM1 and Schnyder corneal dystrophy: Use of hemoglobin (Hb) or heme scavengers, such as haptoglobin or hemopexin, or inhibitors that target the downstream inflammatory consequences of Hb and heme, while possibly capable of favorably altering SCD pathophysiology, may also impact the likelihood of alloimmunization (63).